Metabolic toxicity of the heart: Insights from molecular imaging

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 3, 2010, Pages 147-156

  Iozzo, P ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cardiac steatosis; Diabetes; Fatty acids; Heart failure; Insulin resistance; Myocardial metabolism; Obesity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FATTY ACID; GLUCOSE;

AGING; COMPARATIVE STUDY; DIABETES MELLITUS; ENERGY METABOLISM; FEMALE; HEART DISEASE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; SEX DIFFERENCE; SHORT SURVEY;

ADENOSINE TRIPHOSPHATE; AGING; DIABETES MELLITUS; ENERGY METABOLISM; FATTY ACIDS; FEMALE; GLUCOSE; HEART DISEASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OBESITY; OXYGEN CONSUMPTION; PHOSPHOCREATINE; POSITRON-EMISSION TOMOGRAPHY; SEX FACTORS;

EID: 77349094509     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.08.011     Document Type: Short Survey

References (96)

1. Schelbert H.R. Coronary circulatory function abnormalities in insulin resistance. Insights from positron emission tomography. J Am Coll Cardiol 53 (2009) S3-S8
2. Iozzo P., Chareonthaitawee P., Di Terlizzi M., Betteridge D.J., Ferrannini E., and Camici P.G. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab 282 (2002) E1163-E1171
3. Knaapen P., Germans T., Knuuti J., Paulus W.J., Dijkmans P.A., Allaart C.P., et al. Myocardial energetics and efficiency: current status of the noninvasive approach. Circulation 115 (2007) 918-927
4. Kates A.M., Herrero P., Dence C., Soto P., Srinivasan M., Delano D.G., et al. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 41 (2003) 293-299
5. Kankaanpää M., Lehto H.R., Pärkkä J.P., Komu M., Viljanen A., Ferrannini E., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91 (2006) 4689-4695
6. Szczepaniak L.S., Dobbins R.L., Metzger G.J., Sartoni-D'Ambrosia G., Arbique D., Vongpatanasin W., et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49 (2003) 417-423
7. Okada M., Mitsunami K., Inubushi T., and Kinoshita M. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med 39 (1998) 772-782
8. Nakae I., Mitsunami K., Matsuo S., Matsumoto T., Morikawa S., Inubushi T., et al. Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy. Magn Reson Med Sci 3 (2004) 19-25
9. Tuunanen H., Engblom E., Naum A., Någren K., Hesse B., Airaksinen K.E., et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114 (2006) 2130-2137
10. Sundell J., Nuutila P., Laine H., Luotolahti M., Kalliokoski K., Raitakari O., et al. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes 51 (2002) 1125-1130
11. Choi Y., Brunken R.C., Hawkins R.A., Huang S.C., Buxton D.B., Hoh C.K., et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-d-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 20 (1993) 308-318
12. Nuutila P., Knuuti M.J., Raitakari M., Ruotsalainen U., Teräs M., Voipio-Pulkki L.M., et al. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Phys 267 (1994) E941-E946
13. Takala T.O., Nuutila P., Katoh C., Luotolahti M., Bergman J., Mäki M., et al. Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation. Am J Physiol 277 (1999) E585-E590
14. Slot J.W., Geuze H.J., Gigengack S., James D.E., and Lienhard G.E. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A 88 (1991) 7815-7819
15. Peterson L.R., Herrero P., McGill J., Schechtman K.B., Kisrieva-Ware Z., Lesniak D., et al. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes 57 (2008) 32-40
16. Nuutila P., Koivisto V.A., Knuuti J., Ruotsalainen U., Teräs M., Haaparanta M., et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89 (1992) 1767-1774
17. Reingold J.S., McGavock J.M., Kaka S., Tillery T., Victor R.G., and Szczepaniak L.S. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289 (2005) E935-E939
18. Hammer S., van der Meer R.W., Lamb H.J., Schär M., de Roos A., Smit J.W., et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 93 (2008) 497-503
19. van der Meer R.W., Hammer S., Lamb H.J., Frölich M., Diamant M., Rijzewijk L.J., et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 93 (2008) 2702-2708
20. Chareonthaitawee P., Kaufmann P.A., Rimoldi O., and Camici P.G. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 50 (2001) 151-161
21. Herrero P., Soto P.F., Dence C.S., Kisrieva-Ware Z., Delano D.A., Peterson L.R., et al. Impact of hormone replacement on myocardial fatty acid metabolism: potential role of estrogen. J Nucl Cardiol 12 (2005) 574-581
22. Peterson L.R., Soto P.F., Herrero P., Schechtman K.B., Dence C., and Gropler R.J. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 14 (2007) 573-581
23. Peterson L.R., Soto P.F., Herrero P., Mohammed B.S., Avidan M.S., Schechtman K.B., et al. Impact of gender on the myocardial metabolic response to obesity. JACC Cardiovasc Imaging 1 (2008) 424-433
24. Nuutila P., Knuuti M.J., Mäki M., Laine H., Ruotsalainen U., Teräs M., et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44 (1995) 31-36
25. Köstler H., Landschütz W., Koeppe S., Seyfarth T., Lipke C., Sandstede J., et al. Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magn Reson Med 56 (2006) 907-911
26. Duvernoy C.S., Rattenhuber J., Seifert-Klauss V., Bengel F., Meyer C., and Schwaiger M. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women. J Gend Specif Med 4 (2001) 21-27
27. Peterson L.R., Eyster D., Dávila-Román V.G., Stephens A.L., Schechtman K.B., Herrero P., et al. Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women. Am Heart J 142 (2001) 641-647
28. Uren N.G., Camici P.G., Melin J.A., Bol A., de Bruyne B., Radvan J., et al. Effect of aging on myocardial perfusion riserve. J Nucl Med 36 (1995) 2032-2036
29. Kates A.M., Herrero P., Dence C., Soto P., Srinivasan M., Delano D.G., et al. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 41 (2003) 293-299
30. van der Meer R.W., Rijzewijk L.J., Diamant M., Hammer S., Schär M., Bax J.J., et al. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 29 (2008) 1516-1522
31. Schocke M.F., Metzler B., Wolf C., Steinboeck P., Kremser C., Pachinger O., et al. Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging 21 (2003) 553-559
32. Standl E., and Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia 43 (2000) 1455-1469
33. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
34. Sundell J., Laine H., Nuutila P., Rönnemaa T., Luotolahti M., Raitakari O., et al. The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes. Diabetologia 45 (2002) 775-782
35. Iozzo P., Chareonthaitawee P., Rimoldi O., Betteridge D.J., Camici P.G., and Ferrannini E. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes. Diabetologia 45 (2002) 1404-1409
36. Søndergaard H.M., Bøttcher M., Marie Madsen M., Schmitz O., Hansen S.B., Nielsen T.T., et al. Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease. J Clin Endocrinol Metab 91 (2006) 4854-4861
37. Lautamäki R., Airaksinen K.E., Seppänen M., Toikka J., Härkönen R., Luotolahti M., et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes 55 (2006) 511-516
38. Iozzo P., Chareonthaitawee P., Dutka D., Betteridge D.J., Ferrannini E., and Camici P.G. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51 (2002) 3020-3024
39. vom Dahl J., Herman W.H., Hicks R.J., Ortiz-Alonso F.J., Lee K.S., Allman K.C., et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation 88 (1993) 395-404
40. Dutka D.P., Pitt M., Pagano D., Mongillo M., Gathercole D., Bonser R.S., et al. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol 48 (2006) 2225-2231
41. Utriainen T., Takala T., Luotolahti M., Rönnemaa T., Laine H., Ruotsalainen U., et al. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 41 (1998) 555-559
42. Knuuti J., Takala T.O., Någren K., Sipilä H., Turpeinen A.K., Uusitupa M.I., et al. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia 44 (2001) 184-187
43. Peterson L.R., Herrero P., Schechtman K.B., Racette S.B., Waggoner A.D., Kisrieva-Ware Z., et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109 (2004) 2191-2196
44. McGavock J.M., Lingvay I., Zib I., Tillery T., Salas N., Unger R., et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116 (2007) 1170-1175
45. Rijzewijk L.J., van der Meer R.W., Smit J.W., Diamant M., Bax J.J., Hammer S., et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52 (2008) 1793-1799
46. Perseghin G., Ntali G., De Cobelli F., Lattuada G., Esposito A., Belloni E., et al. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 30 (2007) 1520-1526
47. Scheuermann-Freestone M., Madsen P.L., Manners D., Blamire A.M., Buckingham R.E., Styles P., et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107 (2003) 3040-3046
48. Diamant M., Lamb H.J., Groeneveld Y., Endert E.L., Smit J.W., Bax J.J., et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42 (2003) 328-335
49. Metzler B., Schocke M.F., Steinboeck P., Wolf C., Judmaier W., Lechleitner M., et al. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson 4 (2002) 493-502
50. Hammer S., van der Meer R.W., Lamb H.J., de Boer H.H., Bax J.J., de Roos A., et al. Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 295 (2008) E714-E718
51. Hammer S., Snel M., Lamb H.J., Jazet I.M., van der Meer R.W., Pijl H., et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 52 (2008) 1006-1012
52. Viljanen A.P.M., Karmi A., Borra R., Pärkkä J.P., Lepomäki V., Parkkola R., et al. Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass and cardiac work in obese adults. Am J Cardiol 103 (2009) 1721-1726
53. Hällsten K., Virtanen K.A., Lönnqvist F., Janatuinen T., Turiceanu M., Rönnemaa T., et al. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. Diabet Med 21 (2004) 1280-1287
54. Lautamäki R., Airaksinen K.E., Seppänen M., Toikka J., Luotolahti M., Ball E., et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study. Diabetes 54 (2005) 2787-2794
55. van der Meer R.W., Rijzewijk L.J., de Jong H.W., Lamb H.J., Lubberink M., Romijn J.A., et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 119 (2009) 2069-2077
56. Zib I., Jacob A.N., Lingvay I., Salinas K., McGavock J.M., Raskin P., et al. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med 55 (2007) 230-236
57. Sasaki H., Asanuma H., Fujita M., Takahama H., Wakeno M., Ito S., et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 119 (2009) 2568-2577
58. Katz A.M. Heart failure: pathophysiology, molecular biology, and clinical management (2000), Lippincott Williams & Wilkins, Philadelphia, PA
59. Mohan S.B., Parker M., Wehbi M., and Douglass P. Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Cleve Clin J Med 69 (2002) 481-487
60. Tamaki N., Magata Y., Takahashi N., Kawamoto M., Torizuka T., Yonekura Y., et al. Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states. Ann Nucl Med 6 (1992) 221-228
61. Paternostro G., Camici P.G., Lammerstma A.A., Marinho N., Baliga R.R., Kooner J.S., et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 98 (1996) 2094-2099
62. Di Carli M., Czernin J., Hoh C.K., Gerbaudo V.H., Brunken R.C., Huang S.C., et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 91 (1995) 1944-1951
63. Mäki M.T., Haaparanta M., Nuutila P., Oikonen V., Luotolahti M., Eskola O., et al. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. J Nucl Med 39 (1998) 1320-1327
64. Taylor M., Wallhaus T.R., Degrado T.R., Russell D.C., Stanko P., Nickles R.J., et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med 42 (2001) 55-62
65. Ingwall J.S., Kramer M.F., Fifer M.A., Lorell B.H., Shemin R., Grossman W., et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 313 (1985) 1050-1054
66. Neubauer S., Horn M., Cramer M., Harre K., Newell J.B., Peters W., et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96 (1997) 2190-2196
67. Tian R., and Ingwall J.S. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol 270 (1996) H1207-H1216
68. 1-adrenergic receptor transgenic mice. J Mol Cell Cardiol 35 (2003) 389-397
69. Nakae I., Mitsunami K., Omura T., Yabe T., Tsutamoto T., Matsuo S., et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42 (2003) 1587-1593
70. Vogt M., Motz W.H., Schwartzkopf B., and Strauer B.E. Pathophysiology and clinical aspects of hypertensive hypertrophy. Eur Heart J 14 Suppl. D (1993) 2-7
71. Katz A.M. Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses. J Cell Mol Med 7 (2003) 1-10
72. Laine H., Katoh C., Luotolahti M., Yki-Järvinen H., Kantola I., Jula A., et al. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation 100 (1999) 2425-2430
73. de las Fuentes L., Herrero P., Peterson L.R., Kelly D.P., Gropler R.J., and Dávila-Román V.G. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 41 (2003) 83-87
74. Nuutila P., Mäki M., Laine H., Knuuti M.J., Ruotsalainen U., Luotolahti M., et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest 96 (1995) 1003-1009
75. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., and Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42 (1999) 246-253
76. Lamb H.J., Beyerbacht H.P., van der Laarse A., Stoel B.C., Doornbos J., van der Wall E.E., et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99 (1999) 2261-2267
77. 31P-MRS compared to echocardiographic findings in patients with hypertensive heart disease without overt systolic dysfunction-preliminary results. Eur J Radiol (2008) [Epub ahead of print]
78. Stolen K.Q., Kemppainen J., Kalliokoski K.K., Hällsten K., Luotolahti M., Karanko H., et al. Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy. J Card Fail 10 (2004) 132-140
79. Weismüller S., Czernin J., Sun K.T., Fung C., Phelps M.E., and Schelbert H.R. Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy. Am J Card Imaging 10 (1996) 154-162
80. Kronenberg M.W., Cohen G.I., Leonen M.F., Mladsi T.A., and Di Carli M.F. Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy. J Nucl Cardiol 13 (2006) 544-553
81. Tuunanen H., Engblom E., Naum A., Scheinin M., Någren K., Airaksinen J., et al. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail 12 (2006) 644-652
82. Bengel F.M., Permanetter B., Ungerer M., Nekolla S., and Schwaiger M. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate -comparison between the normal and failing human heart. Eur J Nucl Med 27 (2000) 319-326
83. Dávila-Román V.G., Vedala G., Herrero P., de las Fuentes L., Rogers J.G., Kelly D.P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 271-277
84. Stolen K.Q., Kemppainen J., Kalliokoski K.K., Luotolahti M., Viljanen T., Nuutila P., et al. Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy. J Nucl Cardiol 10 (2003) 447-455
85. Mjos O.D. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 50 (1971) 1386-1389
86. Tuunanen H., Engblom E., Naum A., Någren K., Hesse B., Airaksinen K.E., et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114 (2006) 2130-2137
87. 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study. Acad Radiol 10 (2003) 1187-1192
88. Hardy C.J., Weiss R.G., Bottomley P.A., and Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 122 (1991) 795-801
89. Beer M., Seyfarth T., Sandstede J., Landschutz W., Lipke C., Kostler H., et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40 (2002) 1267-1274
90. Perseghin G., De Cobelli F., Esposito A., Belloni E., Lattuada G., Canu T., et al. Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training. Heart 95 (2009) 630-635
91. Beer M., Wagner D., Myers J., Sandstede J., Köstler H., Hahn D., et al. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy. J Am Coll Cardiol 51 (2008) 1883-1891
92. Tuunanen H., Engblom E., Naum A., Någren K., Scheinin M., Hesse B., et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation 118 (2008) 1250-1258
93. Fragasso G., Perseghin G., De Cobelli F., Esposito A., Palloshi A., Lattuada G., et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 27 (2006) 942-948
94. Lee L., Campbell R., Scheuermann-Freestone M., Taylor R., Gunaruwan P., Williams L., et al. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation 112 (2005) 3280-3288
95. Kankaanpää M., Lehto H.R., Pärkkä J.P., Komu M., Viljanen A., Ferrannini E., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91 (2006) 4689-4695
96. Perseghin G., Lattuada G., De Cobelli F., Esposito A., Belloni E., Ntali G., et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 47 (2008) 51-58